FT. LAUDERDALE, Fla., Jan 8 /PRNewswire/ -- GMP Companies, Inc. is pleased to announce the completion of its Series A-1 Convertible Preferred Stock private placement offering. The Company raised a total of $17.2 million. Proceeds will be used to fund the growth of LifeSync Corporation, a wholly owned subsidiary of GMP Companies, Inc.
LifeSync Corporation is a medical device company dedicated to the continued development, marketing and sale of the LifeSync(R) Wireless System. The LifeSync(R) System is the first wireless electrocardiogram (ECG) data communication system appropriate for use in hospital and outpatient settings where cardiac ECG and respiration monitoring are required. The LifeSync(R) System is based on Bluetooth(R) technology and interfaces with existing patient monitoring equipment to allow healthcare facilities to monitor patients wirelessly. The system is used with LifeSync LeadWear(R) disposable products which replace traditional reusable lead wires. The LifeSync(R) System offers several clinical benefits including significantly increased accuracy of patient alarms and decreased risk to patients of hospital acquired infections. LifeSync’s products and systems are FDA approved and sold to hospitals and stress labs across the United States. The Company believes the LifeSync(R) System, when used in conjunction with existing patient monitoring systems, is the new standard for ECG monitoring.
Investors in this private placement included Janus; MPM Capital; BBT Fund, a Bass family affiliate; and Louisiana Ventures LP.
For more information please call 1-888-723-3310 or visit our web site at www.LifeSyncCorp.com.
GMP Companies, Inc.
CONTACT: GMP Companies, Inc., +1-888-723-3310
